Package Leaflet: Information for the User
Atorvastatina Teva-ratio 10 mg film-coated tablets EFG
Atorvastatina Teva-ratio 20 mg film-coated tablets EFG
Atorvastatina Teva-ratio 30 mg film-coated tablets
Atorvastatina Teva-ratio 40 mg film-coated tablets EFG
Atorvastatina Teva-ratio 60 mg film-coated tablets
Atorvastatina Teva-ratio 80 mg film-coated tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack and other information
Atorvastatina Teva-ratio belongs to a group of medicines known as statins, which are lipid-lowering medicines.
Atorvastatina Teva-ratio is used to lower lipids such as cholesterol and triglycerides in the blood when a low-fat diet and lifestyle changes on their own have not worked. If you are at high risk of heart disease, Atorvastatina Teva-ratio can also be used to reduce this risk even if your cholesterol levels are normal. During treatment, you should follow a standard cholesterol-lowering diet.
Do not take Atorvastatina Teva-ratio
Warnings and precautions
Consult your doctor or pharmacist before starting to take atorvastatin:
In any of these cases, your doctor may indicate that you should have blood tests before and possibly during treatment with this medicine to predict the risk of muscle-related side effects. It is known that the risk of muscle-related side effects (e.g. rhabdomyolysis) increases when certain medicines are taken at the same time (see section 2 "Other medicines and Atorvastatina Teva-ratio").
Also, inform your doctor or pharmacist if you experience constant muscle weakness. Tests and additional medication may be necessary to diagnose and treat this problem.
While taking this medicine, your doctor will check if you have diabetes or are at risk of developing diabetes. This risk of diabetes increases if you have high levels of sugar and fat in the blood, are overweight, and have high blood pressure.
Other medicines and Atorvastatina Teva-ratio
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
There are some medicines that can change the effect of atorvastatin or the effects of these medicines may be changed by atorvastatin. This type of interaction can decrease the effect of one or both medicines. Alternatively, it could increase the risk or severity of side effects, including a serious condition that causes muscle breakdown known as rhabdomyolysis described in section 4:
Taking Atorvastatina Teva-ratio with food and drinks
See section 3 for instructions on how to take atorvastatin. Please note the following:
Grapefruit juice
Do not take more than one or two small glasses of grapefruit juice per day because large quantities of grapefruit juice can alter the effects of atorvastatin.
Alcohol
Avoid drinking too much alcohol while taking this medicine. See the details in section 2 "Warnings and precautions".
Pregnancy and breast-feeding
DO NOT take atorvastatin if you are pregnant, think you may be pregnant, or are planning to become pregnant.
DO NOT take atorvastatin if you are of childbearing age unless you are using adequate contraceptive measures.
DO NOT take atorvastatin if you are breast-feeding your child.
If you are pregnant or breast-feeding, think you may be pregnant, or are planning to become pregnant, consult your doctor or pharmacist before taking this medicine.
The safety of atorvastatin during pregnancy and breast-feeding has not been established.
Consult your doctor or pharmacist before using any medicine.
Driving and using machines
Normally, this medicine does not affect your ability to drive or use machines. However, do not drive if this medicine affects your ability to drive. Do not use tools or machines if this medicine affects your ability to use them.
Atorvastatina Teva-ratio contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; this is essentially "sodium-free".
Follow the instructions for administration of this medicine exactly as indicated by your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist again.
Before starting treatment, your doctor will put you on a low-cholesterol diet, which you should also follow during treatment with this medicine.
The initial dose of atorvastatin is 10 mg once a day in adults and children from 10 years of age. Your doctor may increase it if necessary until you reach the dose you need. Your doctor will adjust the dose at intervals of 4 weeks or more. The maximum dose of atorvastatin is 80 mg once a day.
The tablets of Atorvastatina Teva-ratio should be swallowed whole with a glass of water and can be taken at any time of day with or without food. However, try to take your tablet at the same time every day.
Atorvastatina Teva-ratio 20 mg, 40 mg, and 80 mg
The tablet can be divided into equal doses.
Your doctor will decide the duration of treatment with Atorvastatina Teva-ratio
Ask your doctor if you think the effect of this medicine is too strong or too weak.
If you take more Atorvastatina Teva-ratio than you should
If you accidentally take too many atorvastatin tablets (more than your usual daily dose), consult your doctor or the nearest hospital.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, telephone 91 562 04 20, indicating the medicine and the amount ingested.
If you forget to take Atorvastatina Teva-ratio
If you forget to take a dose, take the next scheduled dose at the correct time. DO NOT take a double dose to make up for forgotten doses.
If you stop taking Atorvastatina Teva-ratio
If you have any other questions about the use of this medicine or wish to stop treatment, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If you notice any of the following serious side effects or symptoms, stop taking these tablets and inform your doctor immediately or go to the emergency department of the nearest hospital.
Rare: may affect up to 1 in 1,000 people
Very rare: may affect up to 1 in 10,000 people
Other possible side effects with Atorvastatina Teva-ratio
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
Rare: may affect up to 1 in 1,000 people
Very rare: may affect up to 1 in 10,000 people
Frequency not known: cannot be estimated from the available data:
Tell your doctor if you experience weakness in your arms or legs that worsens after periods of activity, double vision, or drooping eyelids, difficulty swallowing, or difficulty breathing.
Possible side effects of some statins (medicines of the same type):
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the packaging after "EXP". The expiry date is the last day of the month indicated.
This medicine does not require special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Dispose of the packaging and any unused medicine in the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.
Composition of Atorvastatina Teva-ratio
Each tablet contains 10 mg of atorvastatin (as atorvastatin calcium).
Each tablet contains 20 mg of atorvastatin (as atorvastatin calcium).
Each tablet contains 30 mg of atorvastatin (as atorvastatin calcium).
Each tablet contains 40 mg of atorvastatin (as atorvastatin calcium).
Each tablet contains 60 mg of atorvastatin (as atorvastatin calcium).
Each tablet contains 80 mg of atorvastatin (as atorvastatin calcium).
Tablet core: microcrystalline cellulose (E 460), calcium carbonate (E 170), maltose, sodium croscarmellose (E 466), polysorbate 80 (E 433), and aluminum and magnesium metasilicate and magnesium stearate (E 470b).
Film coating: hypromellose (E 464), hydroxypropylcellulose (E 463), triethyl citrate (E 1505), polysorbate 80 (E 433), and titanium dioxide (E 171)
Appearance ofAtorvastatina Teva-ratioand Package Contents
Atorvastatina Teva-ratio 10 mg are film-coated tablets, white to off-white, elliptical, biconvex, with one face engraved with "10" and the other face smooth. Dimensions: Approx. 8 mm x 4 mm.
Atorvastatina Teva-ratio 20 mg are film-coated tablets, white to off-white, elliptical, biconvex, with one face engraved with "20" and a score on the other face. Dimensions: Approx. 10 mm x 6 mm.
Atorvastatina Teva-ratio 30 mg are film-coated tablets, white to off-white, elliptical, biconvex, with one face with the inscription "30" in relief and the other face smooth. Dimensions: Approx. 12 mm x 6 mm.
Atorvastatina Teva-ratio 40 mg are film-coated tablets, white to off-white, elliptical, biconvex, with one face engraved with "40" and a score on the other face. Dimensions: Approx. 13 mm x 7 mm.
Atorvastatina Teva-ratio 60 mg are film-coated tablets, white to off-white, elliptical, biconvex, with one face engraved with "60" and smooth on the other face. Dimensions: Approx. 14 mm x 8 mm.
Atorvastatina Teva-ratio 80 mg are film-coated tablets, white to off-white, elliptical, biconvex, with one face engraved with "80" and a score on the other face. Dimensions: Approx. 16 mm x 9 mm.
Atorvastatina Teva-ratio 10 mg is presented in blisters of 10, 14, 15, 28, 30, 50, 56, 60, 90, 98, 100, or 105 tablets, in single-dose precut blisters of 10x1, 14x1, 15x1, 28x1, 30x1, 50x1, 56x1, 60x1, 90x1, 98x1, 100x1, or 105x1 tablets, and in bottles of 28, 30, 50, 90, 100, 250, or 500 tablets.
Atorvastatina Teva-ratio 20 mg is presented in blisters of 10, 14, 15, 28, 30, 50, 56, 60, 90, 98, 100, or 105 tablets, in single-dose precut blisters of 10x1, 14x1, 15x1, 28x1, 30x1, 50x1, 56x1, 60x1, 90x1, 98x1, 100x1, or 105x1 tablets, and in bottles of 28, 30, 50, 90, 100, 250, 500, or 1,000 tablets.
Atorvastatina Teva-ratio 30 mg is presented in blisters of 10, 14, 15, 28, 30, 50, 56, 60, 90, 98, 100, or 105 tablets, in single-dose precut blisters of 10x1, 14x1, 15x1, 28x1, 30x1, 50x1, 56x1, 60x1, 90x1, 98x1, 100x1, or 105x1 tablets, and in bottles of 28, 30, 50, 90, or 100 tablets.
Atorvastatina Teva-ratio 40 mg is presented in blisters of 10, 14, 15, 28, 30, 50, 56, 60, 90, 98, 100, or 105 tablets, in single-dose precut blisters of 10x1, 14x1, 15x1, 28x1, 30x1, 50x1, 56x1, 60x1, 90x1, 98x1, 100x1, or 105x1 tablets, and in bottles of 28, 30, 50, 90, 100, 250, or 500 tablets.
Atorvastatina Teva-ratio 60 mg is presented in blisters of 10, 14, 15, 28, 30, 50, 56, 60, 90, 98, 100, or 105 tablets, in single-dose precut blisters of 10x1, 14x1, 15x1, 28x1, 30x1, 50x1, 56x1, 60x1, 90x1, 98x1, 100x1, or 105x1 tablets, and in bottles of 28, 30, 50, 90, or 100 tablets.
Atorvastatina Teva-ratio 80 mg is presented in blisters of 10, 14, 15, 28, 30, 50, 56, 60, 90, 98, 100, or 105 tablets, in single-dose precut blisters of 10x1, 14x1, 15x1, 28x1, 30x1, 50x1, 56x1, 60x1, 90x1, 98x1, 100x1, or 105x1 tablets, and in bottles of 28, 30, 50, 90, 100, or 250 tablets.
Only some pack sizes may be marketed.
Marketing Authorization Holder
Teva B.V.
Swensweg 5,
2031GA Haarlem,
Netherlands
Manufacturer
Teva Pharma, S.L.U.
Polígono Malpica, Calle C nº 4.
50016 Zaragoza, Spain.
You can request more information about this medication by contacting the local representative of the marketing authorization holder:
Teva Pharma, S.L.U.
C/ Anabel Segura, 11, Edificio Albatros B, 1ª planta
28108, Alcobendas, Madrid (Spain)
Date of the last revision of this prospectus: August 2024
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
You can access detailed and updated information about this medication by scanning the QR code included in the packaging with your mobile phone (smartphone). You can also access this information at the following internet address: https://cima.aemps.es/cima